CervoMed
CRVO
15 hedge funds and large institutions have $2.1M invested in CervoMed in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 0 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
50% more capital invested
Capital invested by funds: $1.39M → $2.1M (+$702K)
25% more funds holding
Funds holding: 12 → 15 (+3)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SRCM
Swift Run Capital Management
Charlottesville,
Virginia
|
+$1.4M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$521K |
| 3 |
Renaissance Technologies
New York
|
+$101K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$23.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$15.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$31.2K |
CRVO Hedge Fund Activity: Q1 2018 in Review
15 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q1 2018, worth a combined $2.1M — up 50% from $1.39M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CRVO positions and 0 closed out — a net gain of 3 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Swift Run Capital Management, adding an estimated $1.4M. The largest seller was Virtu Financial, cutting an estimated $31.2K.
- 15 institutional investors held CervoMed (CRVO) as of Q1 2018, up from 12 in Q4 2017.
- Funds reported $2.1M of CervoMed stock for Q1 2018, up 50% quarter-over-quarter.
- 3 funds opened new CervoMed positions in Q1 2018 and 0 closed out, a net change of +3 holders.
- The largest CervoMed buyer in Q1 2018 was Swift Run Capital Management, an estimated $1.4M added.
- The largest CervoMed seller in Q1 2018 was Virtu Financial, an estimated $31.2K sold.
Based on aggregated 13F filings for Q1 2018.